Nanotechnology-based drug delivery systems and alzheimer’s disease

Fritsma, N.L. (2017) Nanotechnology-based drug delivery systems and alzheimer’s disease. Bachelor's Thesis, Biology.

	Text toestemming.pdf - Other Restricted to Backend only Download (117kB)
Preview	Text BIO_BC_2017_NLFritsma.pdf - Published Version Download (1MB) | Preview

Abstract

With an ever increasing occurrence of Alzheimer’s disease (AD) in an equally growing elderly populace, AD has become a general health problem. With currently only conventional drugs being prescribed for symptom management instead of treatment, a quest for new approaches has the scientific world captivated. One of these new approaches is the application of nanotechnology. Despite extensive research in nanotechnology based drug delivery systems (NTDDS) it’s application in clinical activities is lacking compared to other diseases such as cancer. With this manuscript I want to highlight several different NTDDS, their advantages and disadvantages, their possible usability within AD and I also highlight various means of traversing the blood-brain barrier. Lastly I will briefly mention promising therapeutic treatments for AD.

Item Type:	Thesis (Bachelor's Thesis)
Degree programme:	Biology
Thesis type:	Bachelor's Thesis
Language:	English
Date Deposited:	15 Feb 2018 08:31
Last Modified:	15 Feb 2018 08:31
URI:	https://fse.studenttheses.ub.rug.nl/id/eprint/15737

Actions (login required)

View Item